Jan 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2016 Dec 31, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.61 3.94 5.08
(-8.3 pct) (-5.6 pct) (-4.9 pct)
Operating 449 mln 372 mln 460 mln
(+20.8 pct) (+18.6 pct) (+4.0 pct)
Recurring 444 mln 377 mln 451 mln
(+17.7 pct) (+18.2 pct) (+2.3 pct)
Net 303 mln 261 mln 320 mln
(+16.1 pct) (+28.9 pct) (+8.0 pct)
EPS 72.70 yen 60.85 yen 76.55 yen
Ann Div 12.50 yen 12.50 yen
-Q2 div NIL NIL
-Q4 div 12.50 yen 12.50 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T
((Tokyo Headline News Desk +813 6441 1812))